Charles B. Haaser's Insider Trades & SAST Disclosures
Charles B. Haaser's most recent trade in Yield10 Bioscience Inc was a trade of 731 Common Stock done at an average price of $1.5 . Disclosure was reported to the exchange on Aug. 15, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Charles B. Haaser.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Yield10 Bioscience Inc | Charles B. Haaser | VP Finance and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.50 per share. | 15 Aug 2024 | 731 | 5,949 (0%) | 0% | 1.5 | 1,097 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.30 per share. | 15 Feb 2024 | 100,000 | 110,302 (6%) | 5% | 0.3 | 30,000 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Finance and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.59 per share. | 10 Feb 2023 | 979 | 10,300 (0%) | 0% | 3.6 | 3,515 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Finance and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2023 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 10 Aug 2022 | 822 | 11,279 (0%) | 0% | 2.7 | 2,203 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.25 per share. | 01 Mar 2022 | 341 | 12,101 (0%) | 0% | 4.2 | 1,449 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin and CAO | Grant, award, or other acquisition of securities at price $ 3.83 per share. | 10 Feb 2022 | 5,603 | 12,442 (0%) | 0% | 3.8 | 21,459 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2021 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.71 per share. | 01 Sep 2021 | 286 | 4,439 (0%) | 0% | 6.7 | 1,919 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin & Chief Accting Officer | Grant, award, or other acquisition of securities at price $ 16.03 per share. | 01 Mar 2021 | 1,950 | 4,725 (0%) | 0% | 16.0 | 31,259 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin & Chief Accting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.77 per share. | 11 Feb 2021 | 693 | 2,775 (0%) | 0% | 22.8 | 15,780 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin & Chief Accting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.77 per share. | 11 Feb 2021 | 693 | 2,775 (0%) | 0% | 22.8 | 15,780 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin & Chief Accting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2021 | 11,500 | 11,500 | - | - | Stock Option (right to buy) | |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin & Chief Accting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 11 Aug 2020 | 587 | 3,468 (0%) | 0% | 6.6 | 3,845 | Common Stock |
| Yield10 Bioscience Inc | Charles B. Haaser | VP Fin & Chief Accting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 21,000 | 21,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges